Literature DB >> 17245678

[Club drugs].

Ch Senn1, A Bücheli, M Schaub, R Stohler.   

Abstract

The term club drugs refers to a variety of substances which are frequently used in the context of dance events or raves. MDMA - or more commonly ecstasy -, amphetamines, especially methamphetamine, ketamine and newly also GHB (and analoga) are frequently used club drugs. The spectrum of psychoactive effects of theses substances is broad and ranges from stimulant, entactogenig, halluzinogenic, to sedative aspects. Studies show that clubbers can be characterized by their high consumption of several substances; thus, can be considered a potential high risk group. Besides the classical club drug ecstasy more common substances such as alcohol, cannabis, and cocaine are also highly prevalent. The general practitioner has a key function in the early intervention and treatment of potentially problematic club drug users. It seems important that users are being informed in a balanced and evidenced based manner about possible risks associated with their drug use. In order to perform a psychosocial risk assessment an encompassing perspective should be adopted.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17245678     DOI: 10.1024/0040-5930.64.2.109

Source DB:  PubMed          Journal:  Ther Umsch        ISSN: 0040-5930


  3 in total

1.  Repeated doses of methylone, a new drug of abuse, induce changes in serotonin and dopamine systems in the mouse.

Authors:  Raúl López-Arnau; José Martínez-Clemente; Sonia Abad; David Pubill; Jorge Camarasa; Elena Escubedo
Journal:  Psychopharmacology (Berl)       Date:  2014-04-05       Impact factor: 4.530

2.  Drug Checking: A prevention measure for a heterogeneous group with high consumption frequency and polydrug use - evaluation of zurich's drug checking services.

Authors:  Ines Hungerbuehler; Alexander Buecheli; Michael Schaub
Journal:  Harm Reduct J       Date:  2011-06-10

3.  Sex-dependent psychoneuroendocrine effects of THC and MDMA in an animal model of adolescent drug consumption.

Authors:  Alvaro Llorente-Berzal; Emma Puighermanal; Aurelijus Burokas; Andrés Ozaita; Rafael Maldonado; Eva M Marco; Maria-Paz Viveros
Journal:  PLoS One       Date:  2013-11-04       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.